{"nct_id":"NCT00427362","title":"A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)","status":"COMPLETED","status_verified_date":"2008-04","start_date":"2006-05","start_date_type":null,"primary_completion_date":"2007-05","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE3"],"tickers":["ABT"]}